Wolfcamp feature for a deeper undertsanding...http://www.approachresources.com/approach/files/ab/ab8ea30d-8a05-4f46-be96-d0568bc41784.pdf
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress